Skip to main content
Clinical Trials/NCT01559285
NCT01559285CompletedPhase 4

Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters

Pusan National University Hospital1 site in 1 country120 target enrollmentStarted: November 16, 2011Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
120
Locations
1
Primary Endpoint
hemodynamic changes depends on the concentration of ropivacaine

Study Overview

Brief Summary

In this trial, the investigators intend to examine whether the concentration of local anesthetics during epidural analgesia could be modulating factor for change of hemodynamics in patients undergoing major upper abdominal surgery.

Detailed Description

One hundred and twenty patients scheduled for major abdominal surgery under TEA combined general anesthesia were randomized in a double-blinded method to receive one of three different concentration study solutions in 8 ml of volume after the induction of anesthesia: 0.75% ropivacaine (60 mg), 0.375% ropivacaine (30 mg), or 0.2% ropivacane (16 mg).

In each group, the patients were divided into two subgroups at the age of 60 to perform age based analysis. The acquired hemodynamic data after administration of epidural loading dose were compared and analyzed between young and elderly groups in each group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • all of the followings needed.
  • ASA I or II patients
  • 18 to 65 years old
  • undergoing major upper abdominal surgery
  • planned combined thoracic epidural analgesia and general anesthesia

Exclusion Criteria

  • any contraindication to epidural analgesia
  • allergy to local anesthetics of the amide type
  • communication difficulties that would prevent reliable assessment
  • known significant cardiac or respiratory disease
  • patients who were not in cardiac sinus rhythm

Arms & Interventions

0.375% ropivacaine

Active Comparator

0.375% ropivacaine 8ml was injected epidurally after induction of general anesthesia

Intervention: 0.375% ropivacaine concentration (Drug)

0.75% ropivacaine

Active Comparator

0.75% ropivacaine 8ml was injected epidurally after induction of general anesthesia

Intervention: 0.75% ropivacaine concentration (Drug)

0.2% ropivacaine

Active Comparator

0.2% ropivacaine 8ml was injected epidurally after induction of general anesthesia

Intervention: 0.2% ropivacaine concentration (Drug)

Outcomes

Primary Outcomes

hemodynamic changes depends on the concentration of ropivacaine

Time Frame: during 1hour after administration of epidural drug dosing

Systolic blood pressure, diastolic blood pressure, MAP, HR, stroke volume, stroke volume, stroke volume index, stroke volume variation, cardiac output, and cardiac index were continuously measured at 5 minute intervals during 1 hour.

Secondary Outcomes

  • Age based hemodynamic changes depends on the concentration of ropivacaine(during 1hour after administration of epidural drug dosing)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hyeon-Jeong Lee

Assisstant Professor

Pusan National University Hospital

Study Sites (1)

Loading locations...

Similar Trials

Effects of Epidurally Administered... | Clinical Trial